ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	German Clinical Trials Register
Last refreshed on:	8 April 2024
Main ID:	DRKS00011631
Date of registration:	31/01/2017
Prospective Registration:	No
Primary sponsor:	Department of Surgery, Campus Charité Mitte \| Campus Virchow-Klinikum, Charité-Universitätsmedizin Berlin
Public title:	Marker in liver transplant recipients
Scientific title:	Marker in liver transplant recipients - MetabolTX
Date of first enrolment:	09/12/2016
Target sample size:	174
Recruitment status:	Recruiting
URL:	http://drks.de/search/en/trial/DRKS00011631
Study type:	observational
Study design:	Allocation: ; Masking: ; Control: ; Assignment: ; Study design purpose: diagnostic
Phase:

Countries of recruitment
Germany

Contacts

Name:	Felix Krenzien
Address:	Augustenburger Platz 1 13353 Berlin Germany
Telephone:	+49304506552001
Email:	felix.krenzien@charite.de
Affiliation:	Department of Surgery, Campus Charité Mitte \| Campus Virchow-Klinikum, Charité-Universitätsmedizin Berlin

Name:	Felix Krenzien
Address:	Augustenburger Platz 1 13353 Berlin Germany
Telephone:	+49450552001
Email:	felix.krenzien@charite.de
Affiliation:	Department of Surgery, Campus Charité Mitte \| Campus Virchow-Klinikum, Charité-Universitätsmedizin Berlin

Key inclusion & exclusion criteria

Inclusion criteria: liver transplantation, liver resection, healthy volunteer, patient consent
Exclusion criteria: Missing inclusion criteria, no patient consent.

Age minimum: 18 Years
Age maximum: None
Gender: All

Health Condition(s) or Problem(s) studied

LIVERFAILURE

Intervention(s)

Group 1: Inclusion of patients following liver transplantation, analysis of blood according to the clinical routine (POD 0, POD 1, POD 3, POD 7, POD 14, POD 30, 6 Month, 12 Month) observational study, no intervention.
Group 2: Inclusion of patients following liver resection, analysis of blood according to the clinical routine (POD 0, POD 1, POD 3, POD 7, POD 14, POD 30, 6 Month, 12 Month) observational study, no intervention.
Group 3: Inclusion of healthy volunteers, analysis of blood according to the clinical routine (POD 0, POD 1, POD 3, POD 7, POD 14, POD 30, 6 Month, 12 Month) observational study, no intervention.

Primary Outcome(s)

The aim of the study is to determine markers indicating graft failure.

Secondary Outcome(s)

Graft function

Secondary ID(s)

U1111-1191-8111

Source(s) of Monetary Support

Department of Surgery, Campus Charité Mitte | Campus Virchow-Klinikum, Charité-Universitätsmedizin Berlin

Secondary Sponsor(s)

Ethics review

Status: Approved
Approval date: 30/09/2016
Contact:

ethikkommission@charite.de

Ethikkommission der Charité – Universitätsmedizin Berlin

(+49)30-450517222

ethikkommission@charite.de

Results

Results available:
Date Posted:
Date Completed:
URL:	http://drks.de/search/en/trial/DRKS00011631#studyResults

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.